Files
2026-07-06 17:28:36 -04:00

4.8 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Medicaid participants; treatment involving the prescription of opioids, payment. Medicaid participants; treatment involving the prescription of opioids; payment. Prohibits licensed providers from requiring payment from Medicaid participants for the prescription of an opioid for the management of pain or the prescription of buprenorphine-containing products, methadone, or other opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration for medication-assisted treatment of opioid addiction, regardless of whether the provider participates in the state plan for medical assistance. us/states/va Virginia General Assembly 2022 SB 594 Virginia SB 594 (2022)
bill
enacted
Todd E. Pillion
3 25 6 2022-01-12 2022-04-08 openstates ocd-bill/9727b688-3f38-4d36-b5e3-5352104917e7 https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+SB594 6ed79162a501bdc046b43946b4676215d6ceaf543b618894fe0df3bb43957c93 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia SB 594 (2022) — Medicaid participants; treatment involving the prescription of opioids, payment.

Medicaid participants; treatment involving the prescription of opioids; payment. Prohibits licensed providers from requiring payment from Medicaid participants for the prescription of an opioid for the management of pain or the prescription of buprenorphine-containing products, methadone, or other opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration for medication-assisted treatment of opioid addiction, regardless of whether the provider participates in the state plan for medical assistance.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. CHAP0214 (committee substitute) — source
  2. Prefiled and ordered printed; offered 01/12/22 22103669D (committee substitute) — source
  3. SB594ER (committee substitute) — source

Votes

  • Constitutional reading dispensed (40-Y 0-N) — 400 (pass) · upper
  • Reported from Education and Health (15-Y 0-N) — 150 (pass) · upper
  • VOTE: Passage (100-Y 0-N) — 990 (pass) · lower
  • Constitutional reading dispensed (40-Y 0-N) — 400 (pass) · upper
  • Passed Senate (40-Y 0-N) — 400 (pass) · upper
  • Reported from Health, Welfare and Institutions (19-Y 2-N) — 192 (pass) · lower

Sponsors

  • Todd E. Pillion — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2022-01-12 Prefiled and ordered printed; offered 01/12/22 22103669D introduction
  • 2022-01-12 Referred to Committee on Education and Health referral-committee
  • 2022-01-21 Impact statement from DPB (SB594)
  • 2022-01-31 Assigned Education sub: Health Professions referral-committee
  • 2022-02-10 Reported from Education and Health (15-Y 0-N) committee-passage
  • 2022-02-11 Constitutional reading dispensed (40-Y 0-N)
  • 2022-02-14 Read second time and engrossed reading-2
  • 2022-02-14 Constitutional reading dispensed (40-Y 0-N)
  • 2022-02-14 Passed Senate (40-Y 0-N) passage
  • 2022-02-22 Placed on Calendar
  • 2022-02-22 Read first time reading-1
  • 2022-02-22 Referred to Committee on Health, Welfare and Institutions referral-committee
  • 2022-02-24 Reported from Health, Welfare and Institutions (19-Y 2-N) committee-passage
  • 2022-02-28 Read second time reading-2
  • 2022-03-01 Passed by for the day
  • 2022-03-02 Read third time reading-3
  • 2022-03-02 Passed House (100-Y 0-N) passage
  • 2022-03-02 VOTE: Passage (100-Y 0-N)
  • 2022-03-07 Enrolled
  • 2022-03-08 Impact statement from DPB (SB594ER)
  • 2022-03-08 Signed by President
  • 2022-03-08 Signed by Speaker
  • 2022-03-22 Enrolled Bill Communicated to Governor on March 22, 2022
  • 2022-03-22 Governor's Action Deadline 11:59 p.m., April 11, 2022
  • 2022-04-08 Approved by Governor-Chapter 214 (effective 7/1/22) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/9727b688-3f38-4d36-b5e3-5352104917e7. Confidence: reported (aggregated from official Virginia legislature records).